CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors

Cell

Volumn 152, Issue 5, 2013, Pages 1077-1090

  Mo, Wei ^a   Chen, Jian ^a   Patel, Amish ^a   Zhang, Liang ^a   Chau, Vincent ^a   Li, Yanjiao ^a   Cho, Woosung ^a   Lim, Kyun ^a   Xu, Jing ^a   Lazar, Alexander J ^b   Creighton, Chad J ^c   Bolshakov, Svetlana ^b   McKay, Renée M ^a   Lev, Dina ^b   Le, Lu Q ^a   Parada, Luis F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; CYCLIN D1; PHOSPHATIDYLINOSITOL 3 KINASE; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CELL CYCLE PROGRESSION; ENZYME ACTIVITY; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 84874787432     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.01.053     Document Type: Article

References (60)

1. F. Balkwill The significance of cancer cell expression of the chemokine receptor CXCR4 Semin. Cancer Biol. 14 2004 171 179
2. F. Bertolini, C. Dell'Agnola, P. Mancuso, C. Rabascio, A. Burlini, S. Monestiroli, A. Gobbi, G. Pruneri, and G. Martinelli CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma Cancer Res. 62 2002 3106 3112
3. X.W. Bian, S.X. Yang, J.H. Chen, Y.F. Ping, X.D. Zhou, Q.L. Wang, X.F. Jiang, W. Gong, H.L. Xiao, and L.L. Du Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival Neurosurgery 61 2007 570 578 discussion 578-579
4. J.A. Burger, M. Burger, and T.J. Kipps Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells Blood 94 1999 3658 3667
5. K. Cichowski, T.S. Shih, E. Schmitt, S. Santiago, K. Reilly, M.E. McLaughlin, R.T. Bronson, and T. Jacks Mouse models of tumor development in neurofibromatosis type 1 Science 286 1999 2172 2176
6. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
7. Y. Cui, R.M. Costa, G.G. Murphy, Y. Elgersma, Y. Zhu, D.H. Gutmann, L.F. Parada, I. Mody, and A.J. Silva Neurofibromin regulation of ERK signaling modulates GABA release and learning Cell 135 2008 549 560
8. R.E. Ferner Neurofibromatosis 1 Eur. J. Hum. Genet. 15 2007 131 138
9. M.P. Ghadimi, E.D. Young, R. Belousov, Y. Zhang, G. Lopez, K. Lusby, C. Kivlin, E.G. Demicco, C.J. Creighton, and A.J. Lazar Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors Clin. Cancer Res. 18 2012 2545 2557
10. S. Hoppler, and C.L. Kavanagh Wnt signalling: variety at the core J. Cell Sci. 120 2007 385 393
11. C.M. Johannessen, B.W. Johnson, S.M. Williams, A.W. Chan, E.E. Reczek, R.C. Lynch, M.J. Rioth, A. McClatchey, S. Ryeom, and K. Cichowski TORC1 is essential for NF1-associated malignancies Curr. Biol. 18 2008 56 62
12. G. Johansson, Y.Y. Mahller, M.H. Collins, M.O. Kim, T. Nobukuni, J. Perentesis, T.P. Cripe, H.A. Lane, S.C. Kozma, G. Thomas, and N. Ratner Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors Mol. Cancer Ther. 7 2008 1237 1245
13. D.G. Johnson, and C.L. Walker Cyclins and cell cycle checkpoints Annu. Rev. Pharmacol. Toxicol. 39 1999 295 312
14. N.M. Joseph, J.T. Mosher, J. Buchstaller, P. Snider, P.E. McKeever, M. Lim, S.J. Conway, L.F. Parada, Y. Zhu, and S.J. Morrison The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells Cancer Cell 13 2008 129 140
15. T. Kijima, G. Maulik, P.C. Ma, E.V. Tibaldi, R.E. Turner, B. Rollins, M. Sattler, B.E. Johnson, and R. Salgia Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells Cancer Res. 62 2002 6304 6311
16. T. Koshiba, R. Hosotani, Y. Miyamoto, J. Ida, S. Tsuji, S. Nakajima, M. Kawaguchi, H. Kobayashi, R. Doi, and T. Hori Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression Clin. Cancer Res. 6 2000 3530 3535
17. C. Laverdiere, B.H. Hoang, R. Yang, R. Sowers, J. Qin, P.A. Meyers, A.G. Huvos, J.H. Healey, and R. Gorlick Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma Clin. Cancer Res. 11 2005 2561 2567
18. L.Q. Le, and L.F. Parada Tumor microenvironment and neurofibromatosis type I: connecting the GAPs Oncogene 26 2007 4609 4616
19. L.Q. Le, T. Shipman, D.K. Burns, and L.F. Parada Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas Cell Stem Cell 4 2009 453 463
20. L.Q. Le, C. Liu, T. Shipman, Z. Chen, U. Suter, and L.F. Parada Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development Cancer Res. 71 2011 4686 4695
21. M.H. Lee, and H.Y. Yang Regulators of G1 cyclin-dependent kinases and cancers Cancer Metastasis Rev. 22 2003 435 449
22. Y.M. Li, Y. Pan, Y. Wei, X. Cheng, B.P. Zhou, M. Tan, X. Zhou, W. Xia, G.N. Hortobagyi, D. Yu, and M.C. Hung Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis Cancer Cell 6 2004 459 469
23. C. Liu, Y. Li, M. Semenov, C. Han, G.H. Baeg, Y. Tan, Z. Zhang, X. Lin, and X. He Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 2002 837 847
24. K.K. Mantripragada, G. Spurlock, L. Kluwe, N. Chuzhanova, R.E. Ferner, I.M. Frayling, J.P. Dumanski, A. Guha, V. Mautner, and M. Upadhyaya High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization Clin. Cancer Res. 14 2008 1015 1024
25. A. Müller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, and S.N. Wagner Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
26. A.J. Obaya, and J.M. Sedivy Regulation of cyclin-Cdk activity in mammalian cells Cell. Mol. Life Sci. 59 2002 126 142
27. J.W. Oh, K. Drabik, O. Kutsch, C. Choi, A. Tousson, and E.N. Benveniste CXC chemokine receptor 4 expression and function in human astroglioma cells J. Immunol. 166 2001 2695 2704
28. A. Peled, O. Wald, and J. Burger Development of novel CXCR4-based therapeutics Expert Opin. Investig. Drugs 21 2012 341 353
29. E. Righi, S. Kashiwagi, J. Yuan, M. Santosuosso, P. Leblanc, R. Ingraham, B. Forbes, B. Edelblute, B. Collette, and D. Xing CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer Cancer Res. 71 2011 5522 5534
30. J.B. Rubin, and D.H. Gutmann Neurofibromatosis type 1 - a model for nervous system tumour formation? Nat. Rev. Cancer 5 2005 557 564
31. A.J. Schrader, O. Lechner, M. Templin, K.E. Dittmar, S. Machtens, M. Mengel, M. Probst-Kepper, A. Franzke, T. Wollensak, and P. Gatzlaff CXCR4/CXCL12 expression and signalling in kidney cancer Br. J. Cancer 86 2002 1250 1256
32. A. Sehgal, C. Keener, A.L. Boynton, J. Warrick, and G.P. Murphy CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells J. Surg. Oncol. 69 1998 99 104
33. R. Sengupta, A. Dubuc, S. Ward, L. Yang, P. Northcott, B.M. Woerner, K. Kroll, J. Luo, M.D. Taylor, R.J. Wechsler-Reya, and J.B. Rubin CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma Cancer Res. 72 2012 122 132
34. E. Serra, T. Rosenbaum, U. Winner, R. Aledo, E. Ars, X. Estivill, H.G. Lenard, and C. Lázaro Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations Hum. Mol. Genet. 9 2000 3055 3064
35. C.J. Sherr D-type cyclins Trends Biochem. Sci. 20 1995 187 190
36. S. Singh, U.P. Singh, W.E. Grizzle, and J.W. Lillard Jr. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion Lab. Invest. 84 2004 1666 1676
37. A.K. Srivastava, and S.K. Pandey Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin Mol. Cell. Biochem. 182 1998 135 141
38. R.S. Taichman, C. Cooper, E.T. Keller, K.J. Pienta, N.S. Taichman, and L.K. McCauley Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone Cancer Res. 62 2002 1832 1837
39. J.H. Tonsgard Clinical manifestations and management of neurofibromatosis type 1 Semin. Pediatr. Neurol. 13 2006 2 7
40. K.S. Vogel, L.J. Klesse, S. Velasco-Miguel, K. Meyers, E.J. Rushing, and L.F. Parada Mouse tumor model for neurofibromatosis type 1 Science 286 1999 2176 2179
41. Z. Wang, Q. Ma, Q. Liu, H. Yu, L. Zhao, S. Shen, and J. Yao Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway Br. J. Cancer 99 2008 1695 1703
42. Y. Wang, E. Kim, X. Wang, B.G. Novitch, K. Yoshikawa, L.S. Chang, and Y. Zhu ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities Cell 150 2012 816 830
43. N.M. Warrington, B.M. Woerner, G.C. Daginakatte, B. Dasgupta, A. Perry, D.H. Gutmann, and J.B. Rubin Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1 Cancer Res. 67 2007 8588 8595
44. I.S. Zeelenberg, L. Ruuls-Van Stalle, and E. Roos The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases Cancer Res. 63 2003 3833 3839
45. H. Zheng, L. Chang, N. Patel, J. Yang, L. Lowe, D.K. Burns, and Y. Zhu Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation Cancer Cell 13 2008 117 128
46. Y. Zhou, P.H. Larsen, C. Hao, and V.W. Yong CXCR4 is a major chemokine receptor on glioma cells and mediates their survival J. Biol. Chem. 277 2002 49481 49487
47. Y. Zhu, and L.F. Parada Neurofibromin, a tumor suppressor in the nervous system Exp. Cell Res. 264 2001 19 28
48. Y. Zhu, P. Ghosh, P. Charnay, D.K. Burns, and L.F. Parada Neurofibromas in NF1: Schwann cell origin and role of tumor environment Science 296 2002 920 922
49. C.Y. Zou, K.D. Smith, Q.S. Zhu, J. Liu, I.E. McCutcheon, J.M. Slopis, F. Meric-Bernstam, Z. Peng, W.G. Bornmann, and G.B. Mills Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor Mol. Cancer Ther. 8 2009 1157 1168
50. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
51. S. Courtois-Cox, S.M. Genther Williams, E.E. Reczek, B.W. Johnson, L.T. McGillicuddy, C.M. Johannessen, P.E. Hollstein, M. MacCollin, and K. Cichowski A negative feedback signaling network underlies oncogene-induced senescence Cancer Cell 10 2006 459 472
52. G.L. Dalgliesh, K. Furge, C. Greenman, L. Chen, G. Bignell, A. Butler, H. Davies, S. Edkins, C. Hardy, and C. Latimer Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363
53. S. Jones, X. Zhang, D.W. Parsons, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, and A. Jimeno Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
54. Z. Kan, B.S. Jaiswal, J. Stinson, V. Janakiraman, D. Bhatt, H.M. Stern, P. Yue, P.M. Haverty, R. Bourgon, and J. Zheng Diverse somatic mutation patterns and pathway alterations in human cancers Nature 466 2010 869 873
55. R.D. Morin, M. Mendez-Lago, A.J. Mungall, R. Goya, K.L. Mungall, R.D. Corbett, N.A. Johnson, T.M. Severson, R. Chiu, and M. Field Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma Nature 476 2011 298 303
56. A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, and R.A. Weinberg Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 2005 335 348
57. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, and G.L. Gallia An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
58. D.W. Parsons, M. Li, X. Zhang, S. Jones, R.J. Leary, J.C. Lin, S.M. Boca, H. Carter, J. Samayoa, and C. Bettegowda The genetic landscape of the childhood cancer medulloblastoma Science 331 2011 435 439
59. S.A. Wegner, P.K. Ehrenberg, G. Chang, D.E. Dayhoff, A.L. Sleeker, and N.L. Michael Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1 J. Biol. Chem. 273 1998 4754 4760
60. L.D. Wood, D.W. Parsons, S. Jones, J. Lin, T. Sjöblom, R.J. Leary, D. Shen, S.M. Boca, T. Barber, and J. Ptak The genomic landscapes of human breast and colorectal cancers Science 318 2007 1108 1113